Other secondary clinical outcomes
PRS
EBA analysis was performed among patients with assessable test results in the modified intention-to-treat population after excluding those whose samples were contaminated, who had difficulty in expectorating, or had low-quality sputum samples. As shown in Early bactericidal activity (EBA) of the standard and Parabolic Response Surface (PRS) regimens in the modified intention-to-treat population with assessable results. The number of sputum samples tested at each time point are presented in the figures, after excluding the missing (mainly due to the difficulty of expectorating), contaminated or low-quality sputum samples. No significant between-group differences were identified on EBA